Compare Cigna Corp (CI) vs MasterCard Inc (MA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs MasterCard Inc — how do they compare? Cigna Corp trades at $272.28 (market cap $73.56B), while MasterCard Inc trades at $564.48 (market cap $493.34B). The key difference: MasterCard Inc is far larger — about 6.7× Cigna Corp's market cap, and Cigna Corp pays the higher dividend (2.24%). Which is the better fit depends on your goals.
| CI | MA | |
|---|---|---|
Market Cap | $73.56B | $493.34B |
Sector | Health | Consumer Cyclical |
52-Week High | $311.00 | $598.96 |
52-Week Low | $244.41 | $471.55 |
Enterprise Value | $98.27B | $506.38B |
Dividend Yield | 2.24% | 0.62% |
Volume | — | 4,635,698 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
Mastercard (MA) trades at $564.69, up 0.31% with strong institutional buying interest. The stock shows bullish technical momentum above key support at $560, supported by consistent earnings beats and robust fundamentals including 46.34% net margins. Revenue growth accelerated to $32.79B in 2025, with analysts projecting 17% upside to the $660.85 consensus target. Recent news highlights Mastercard's AI payments expansion in ASEAN and commitment to connect 500 million underbanked people by 2030.
Mastercard presents a compelling growth opportunity with dominant market position and expanding digital payment adoption. Key risks include payment industry disruption from stablecoins and competitive pressures. With 79% analyst buy ratings and strong institutional accumulation, the stock offers quality exposure to global payment growth, though investors should monitor execution on innovation initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →
